Crinetics Pharmaceuticals CRNX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's short- and long-term operating lease liabilities?
- Crinetics Pharmaceuticals (CRNX) reported short- and long-term operating lease liabilities of -$685K in Q1 2026.
- How has Crinetics Pharmaceuticals's short- and long-term operating lease liabilities changed year-over-year?
- Crinetics Pharmaceuticals's short- and long-term operating lease liabilities increased by 24.1% year-over-year, from -$903K to -$685K.